Sunday, October 20, 2019

Sunday, October 20, 2019

Heartland Institute News

Critics say the latest attempt by Congress to reign in prescription drug prices may not work

The Prescription Drug Pricing Reduction Act (PDPRA) is expected to work its way through Congress this fall.

Pharmacology professor, expert speaks out on FDA drug safety

David Gortler, a professor of pharmacology and a former FDA official, says the FDA needs to do more to ensure the quality of drugs delivered to the U.S. market, with particular concern given to generic drugs produced in “sweatshop” countries.

'Right to try' patients should not be charged for treatment, health-care policy adviser speaking as 'health care consumer' says

Terminally and chronically ill patients should not be charged for “right to try” treatments, a health-care policy adviser for an Illinois-based free-market think tank, speaking as “a health-care consumer,” said during a recent interview.

Heartland Institute's Hudgins says U.S. could learn from Japanese drug-approval model

Heartland Institute's Hudgins says U.S. could learn from Japanese drug-approval model

FDA Reporter